Global Prochlorperazine Maleate Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Neurological Disorders
The global Prochlorperazine Maleate market is estimated to be valued at US$1.46 billion in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Prochlorperazine Maleate is a medication used for the treatment of neurological disorders such as nausea, vomiting, and schizophrenia. It belongs to the phenothiazine class of antipsychotic drugs and works by blocking dopamine receptors in the brain. The use of Prochlorperazine Maleate has increased significantly due to its effectiveness in managing these conditions. Market Dynamics: The Prochlorperazine Maleate market is driven by two key factors. Firstly, the increasing prevalence of neurological disorders globally is driving the demand for effective treatment options. Neurological disorders such as schizophrenia and motion sickness are on the rise, leading to a higher demand for medications like Prochlorperazine